SRS278 - Analysing the impact of a consultant-led treat-to-target approach to lipid-lowering therapy in abdominal aortic aneurysm (AAA) patients

View at publisher Summarise with VIRAT
Authors: Leigh Avery, Nikita Chauhan, Jing Yi Kwan, Patrick A. Coughlin, Julian Scott
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Introduction Abdominal aortic aneurysms (AAAs) affect ∼4% of men aged 65–74 and carry substantial cardiovascular risk. Elevated low-density lipoprotein cholesterol (LDL-C) drives atherosclerosis, with each 1 mmol/L reduction lowering major adverse cardiac events (MACE). Despite statins being effective, fewer than 60% of AAA surveillance patients receive therapy. Guidelines recommend intensive lipid-lowering, with targets of

Fields of Study & Subjects

Lipoproteins and Cardiovascular Health Aortic aneurysm repair treatments Blood Pressure and Hypertension Studies

Publication details

Journal / source
British journal of surgery
Volume
113
Issue
Supplement_2
Publication date
1 March 2026
Language
EN